Mizuho Asset Management Co. Ltd. boosted its stake in shares of Clorox Co. (NYSE:CLX) by 72.2% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 1,655 shares of the company’s stock after buying an additional 694 shares during the period. Mizuho Asset Management Co. Ltd.’s holdings in Clorox were worth $229,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the stock. Legal & General Group Plc boosted its position in shares of Clorox by 1.7% in the first quarter. Legal & General Group Plc now owns 682,421 shares of the company’s stock worth $86,041,000 after buying an additional 11,428 shares during the last quarter. First Republic Investment Management Inc. boosted its position in shares of Clorox by 5.7% in the first quarter. First Republic Investment Management Inc. now owns 200,233 shares of the company’s stock worth $25,242,000 after buying an additional 10,868 shares during the last quarter. Shell Asset Management Co. boosted its position in shares of Clorox by 9.6% in the second quarter. Shell Asset Management Co. now owns 103,486 shares of the company’s stock worth $14,321,000 after buying an additional 9,034 shares during the last quarter. Investment Centers of America Inc. boosted its position in shares of Clorox by 14.9% in the first quarter. Investment Centers of America Inc. now owns 9,478 shares of the company’s stock worth $1,199,000 after buying an additional 1,232 shares during the last quarter. Finally, Mount Lucas Management LP boosted its position in shares of Clorox by 45.1% in the first quarter. Mount Lucas Management LP now owns 54,774 shares of the company’s stock worth $6,905,000 after buying an additional 17,030 shares during the last quarter. Institutional investors own 70.17% of the company’s stock.

Clorox Co. (NYSE:CLX) traded up 1.04% during trading on Tuesday, reaching $123.95. The company’s stock had a trading volume of 188,180 shares. Clorox Co. has a 52 week low of $112.75 and a 52 week high of $140.47. The company has a market cap of $16.05 billion, a P/E ratio of 25.19 and a beta of 0.33. The company’s 50 day moving average price is $129.73 and its 200 day moving average price is $130.12.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.28 by $0.02. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business’s revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.44 EPS. On average, equities analysts anticipate that Clorox Co. will post $5.49 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be given a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 2.61%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s payout ratio is 64.91%.

CLX has been the topic of a number of recent research reports. Atlantic Securities upgraded Clorox from a “hold” rating to a “buy” rating and set a $144.00 target price on the stock in a report on Friday. Citigroup Inc. raised their target price on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and issued a $130.00 target price on shares of Clorox in a research report on Thursday, August 4th. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $148.00 target price for the company in a research report on Monday, August 8th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and issued a $134.00 target price (up previously from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Clorox presently has an average rating of “Hold” and a consensus target price of $128.90.

In related news, COO Dawn C. Willoughby sold 10,617 shares of the company’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $131.01, for a total value of $1,390,933.17. Following the completion of the sale, the chief operating officer now owns 20,353 shares in the company, valued at approximately $2,666,446.53. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total transaction of $123,089.75. The disclosure for this sale can be found here. Company insiders own 2.09% of the company’s stock.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.